Copyright
©The Author(s) 2020.
World J Gastroenterol. Jan 14, 2020; 26(2): 219-245
Published online Jan 14, 2020. doi: 10.3748/wjg.v26.i2.219
Published online Jan 14, 2020. doi: 10.3748/wjg.v26.i2.219
Table 1 Participants, interventions, comparisons, outcomes and study design criteria used to define the research question for this systematic review
Variable | Description |
Population | Humans diagnosed with liver failure (ALF/ACLF) |
Intervention | Plasma exchange with or without other alternative liver support systems; no restrictions on dose, duration and type of plasma exchange |
Comparator | Randomized controlled trials/Cohort studies: Standard medical treatment |
Case series/case reports: Nil | |
Outcome | All-cause mortality, changes in liver biochemistry, and survival in non-transplanted patients |
Study design | Randomized Controlled Trials, Cohort studies, Case series, Case reports |
Research question | Does plasmapheresis have an effect on all-cause mortality, changes in liver biochemistry, and survival in non-transplanted patients with ALF/ACLF, compared to standard medical treatment? |
- Citation: Tan EXX, Wang MX, Pang J, Lee GH. Plasma exchange in patients with acute and acute-on-chronic liver failure: A systematic review. World J Gastroenterol 2020; 26(2): 219-245
- URL: https://www.wjgnet.com/1007-9327/full/v26/i2/219.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i2.219